David Bowton to Double-Blind Method
This is a "connection" page, showing publications David Bowton has written about Double-Blind Method.
Connection Strength
0.100
-
Bowton DL, Dmitrienko AA, Israel E, Zeiher BG, Sides GD. Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma. 2005 Feb; 42(1):65-71.
Score: 0.050
-
Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, Douglas IS, Malhotra A, Owens RL, Feinstein DJ, Khan B, Pisani MA, Hyzy RC, Schmidt GA, Schweickert WD, Hite RD, Bowton DL, Masica AL, Thompson JL, Chandrasekhar R, Pun BT, Strength C, Boehm LM, Jackson JC, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Bernard GR, Dittus RS, Ely EW. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med. 2018 12 27; 379(26):2506-2516.
Score: 0.032
-
Surette ME, Koumenis IL, Edens MB, Tramposch KM, Clayton B, Bowton D, Chilton FH. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther. 2003 Mar; 25(3):972-9.
Score: 0.011
-
Sherertz RJ, Heard SO, Raad II, Gentry L, Bowton D, Scuderi P, Hu J, Carruth W, Satishchandra B, Pepe J, Mosenthal A, Burke T, Dupuis J. Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother. 1996 Sep; 40(9):1995-7.
Score: 0.007